Mostrar el registro sencillo del ítem

Artículo

dc.creatorAbubakar, Usmanes
dc.creatorAl-Anazi, Menieres
dc.creatorAlanazi, Zainabes
dc.creatorRodríguez-Baño, Jesúses
dc.date.accessioned2023-04-17T13:52:41Z
dc.date.available2023-04-17T13:52:41Z
dc.date.issued2022-12-28
dc.identifier.citationAbubakar, U., Al-Anazi, M., Alanazi, Z. y Rodríguez-Baño, J. (2022). Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: a systematic review. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2022.12.022.
dc.identifier.issn1876-0341es
dc.identifier.urihttps://hdl.handle.net/11441/144509
dc.description.abstractBackground: There is paucity of data describing the impact of COVID-19 pandemic on antimicrobial resistance. This review evaluated the changes in the rate of multidrug resistant gram negative and gram positive bacteria during the COVID-19 pandemic. Methods: A search was conducted in PubMed, Science Direct, and Google Scholar databases to identify eligible studies. Studies that reported the impact of COVID-19 pandemic on carbapenem-resistant Acinetobacter baumannii (CRAB), carbapenem-resistant Enterobacteriaceae (CRE), extended-spectrum betalactamase inhibitor (ESBL)-producing Enterobacteriaceae, vancomycin-resistant enterococci (VRE), methicillin- resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Pseudomonas aeruginosa (CPE) were selected. Studies published in English language from the start of COVID-19 pandemic to July 2022 were considered for inclusion. Results: Thirty eligible studies were selected and most of them were from Italy (n = 8), Turkey (n = 3) and Brazil (n = 3). The results indicated changes in the rate of multidrug resistant bacteria, and the changes varied between the studies. Most studies (54.5%) reported increase in MRSA infection/colonization during the pandemic, and the increase ranged from 4.6 to 170.6%. Five studies (55.6%) reported a 6.8–65.1% increase in VRE infection/colonization during the pandemic. A 2.4–58.2% decrease in ESBL E. coli and a 1.8–13.3% reduction in ESBL Klebsiella pneumoniae was observed during the pandemic. For CRAB, most studies (58.3%) reported 1.5–621.6% increase in infection/colonization during the pandemic. Overall, studies showed increase in the rate of CRE infection/colonization during the pandemic. There was a reduction in carbapenemresistant E. coli during COVID-19 pandemic, and an increase in carbapenem-resistant K. pneumoniae. Most studies (55.6%) showed 10.4 – 40.9% reduction in the rate of CRPA infection during the pandemic. Conclusion: There is an increase in the rate of multidrug resistant gram positive and gram negative bacteria during the COVID-19 pandemic. However, the rate of ESBL-producing Enterobacteriaceae and CRPA has decrease during the pandemic. Both infection prevention and control strategies and antimicrobial stewardship should be strengthen to address the increasing rate of multidrug resistant gram positive and gram negative bacteria.es
dc.formatapplication/pdfes
dc.format.extent12 p.
dc.language.isoenges
dc.publisherElsevieres
dc.relation.ispartofJournal of Infection and Public Health.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAntimicrobial resistancees
dc.subjectCOVID-19 pandemices
dc.subjectMRSAes
dc.subjectCarbapenem-resistant enterobacteriaceaes
dc.subjectVancomycin-resistant enterococcies
dc.subjectImpactes
dc.subjectGram positivees
dc.subjectGram negativees
dc.titleImpact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: a systematic reviewes
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Cirugíaes
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S1876034122003720?via%3Dihubes
dc.identifier.doi10.1016/j.jiph.2022.12.022es
dc.journaltitleJournal of Infection and Public Healthes
dc.publication.volumen16
dc.publication.issue3
dc.publication.initialPage320
dc.publication.endPage331
dc.publication.endPage

FicherosTamañoFormatoVerDescripción
Impact of COVID-19...pdf692.3KbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional